Treatment Stories
651 articles
The Association of Community Cancer Centers (ACCC) Fights for Equitable Cancer Care
The Association of Community Cancer Centers helps local oncologists access the latest treatment and care information, says Dr. Leigh Boehmer.
President Jimmy Carter—Let’s Win! Pancreatic Cancer PSA
Let’s Win Honorary Chair President Jimmy Carter’s family has been devastated by pancreatic cancer. Join him in supporting our mission.
No Longer a Death Sentence
Dr. Allyson Ocean and Cindy Gavin discuss the mission of Let’s Win to raise awareness of the treatment options for pancreatic cancer.
What Is Pancreatic Cancer?
Learn more about the main different types of pancreatic cancer–adenocarcinoma and pancreatic neuroendocrine tumors.
Diagnosing Pancreatic Cancer: Tests to Expect
What can you expect during pancreatic cancer diagnostic testing? Dr. Gobind Anand offers expert guidance to stay informed throughout the process.
Using a Colon Cancer Drug to Treat Advanced Pancreatic Cancer
A clinical trial tests the effectiveness of an approved colon cancer drug against advanced pancreatic neuroendocrine cancer.
mRNA Pancreatic Cancer Vaccine Trial Heading for Phase II
Dr. Vinod Balachandran provides the latest data on the mRNA pancreatic cancer vaccine, now headed to a phase II clinical trial.
Meet the Researcher: Jeffrey Patterson-Fortin, M.D., Ph.D.
Researcher Dr. Jeffrey Patterson-Fortin focuses on DNA damage repair as he looks for better pancreatic cancer treatments.
Risk Factors and Symptoms of Pancreatic Cancer
In this webinar oncologist Dr. Shaalan Beg outlines pancreatic cancer risk factors and gastroenterologist Dr. Oscar Alvarez explains how he looks at symptoms.
MORE Magazine: The Cancer Campaign That Got Personal
After a diagnosis of stage IV pancreatic cancer, Anne Glauber turned to research to find a treatment that could extend her life.
Faces of Let’s Win: Dr. David Tuveson
Dr. David Tuveson, Director of the Lustgarten Foundation Pancreatic Research Laboratory, explains why pancreatic cancer is so difficult to treat.
Potential Therapy Takes a Two-Prong Attack on Pancreatic Cancer
With a focus on targeting cell metabolism, Dr. Anup Kasi leads a clinical trial of a new agent in combination with gemcitabine.
Surveillance Improves Outcomes for High-Risk Patients
Dr. Michael Goggins provides results for the CAPS5 pancreatic cancer surveillance and screening study for patients at high risk.